• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Eli Lilly & Co (LLY)

Common Stock
Sell: $882.50|Buy: $888.00|Change: 7.91 (0.90%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltzand Olumiant for immunology.

Address

Lilly Corporate Center
Indianapolis
IN
USA
46285

Telephone

+1 317 2962884

Website

https://www.lilly.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Eli Lilly and Co Annual Report for 20252026-02-19T00:00:00
Eli Lilly and Co Fourth Quarter Earnings Conference Call for 20252026-02-06T10:00:00
Eli Lilly and Co Fourth Quarter Earnings Result for 20252026-02-06T00:00:00
Eli Lilly and Co Third Quarter Earnings Conference Call for 20252025-10-30T10:00:00
Eli Lilly and Co Third Quarter Earnings Results for 20252025-10-30T00:00:00
Eli Lilly and Co Second Quarter Earnings Conference Call for 20252025-08-07T10:00:00
Eli Lilly and Co Second Quarter Earnings Results for 20252025-08-07T00:00:00
Eli Lilly and Co Annual General Meeting for 20252025-05-05T08:30:00
Eli Lilly and Co First Quarter Earnings Conference Call for 20252025-05-01T10:00:00
Eli Lilly and Co First Quarter Earnings Results for 20252025-05-01T00:00:00

Previous key dates

NameKey Date
TD Cowen 45th Annual Health Care Conference2025-03-10T09:20:00
TD Cowen's 45th Annual Health Care Conference2025-03-04T13:50:00
Eli Lilly and Co Annual Report for 20242025-02-19T00:00:00
Eli Lilly and Co Fourth Quarter Earnings Conference Call for 20242025-02-06T10:00:00
Eli Lilly and Co Fourth Quarter Earnings Result for 20242025-02-06T00:00:00
43rd Annual J.P. Morgan Healthcare Conference2025-01-14T17:15:00
Eli Lilly and Co Third Quarter Earnings Conference Call for 20242024-10-30T10:00:00
Eli Lilly and Co Third Quarter Earnings Result for 20242024-10-30T00:00:00
Lilly to participate in Morgan Stanley 22nd Annual Global Healthcare Conference2024-09-05T07:45:00
Eli Lilly and Co Second Quarter Earnings Conference Call for 20242024-08-08T10:00:00
Eli Lilly and Co Second Quarter Earnings Result for 20242024-08-08T00:00:00
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference2024-06-10T16:00:00
Eli Lilly and Co Lilly Oncology ASCO Investor Event 20242024-06-02T19:30:00
Eli Lilly and Co Annual General Meeting for 20242024-05-06T08:30:00
Eli Lilly and Co First Quarter Earnings Conference Call for 20242024-04-30T10:00:00
Eli Lilly and Co First Quarter Earnings Result for 20242024-04-30T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.